Indegene information

Indegene
Formerly	Indegene Lifesystems
Company type	Public
Traded as	NSE: INDGN; BSE: 544172;
Industry	Contract research; Health information technology;
Founded	1998; 26 years ago
Founders	Rajesh Nair; Manish Gupta; Sanjay Parikh; Anand Kiran; Gaurav Kapoor
Headquarters	Bangalore, India
Area served	Worldwide
Key people	Manish Gupta (CEO)
Revenue	₹2,306 crore (US$290 million) (FY23)
Net income	₹266 crore (US$33 million) (FY23)
Owners	N. S. Raghavan (23.64%); Carlyle Group (20.42%); Brighton Park Capital (12.07%);
Number of employees	4,100 (2021)
Website	www.indegene.com

Indegene Limited is an Indian company that provides research and commercialization services to biopharmaceutical and healthcare enterprises.^[5]^[6]^[7] Based in Bangalore, the company specializes in pharmaceutical marketing, clinical trials, pharmacovigilance, medical and regulatory affairs, and health informatics.^[4]^[8]

^ Mendonca, Jochelle (28 November 2015). "Healthcare IT firm Indegene targets $250 million in revenue by 2020, looking at Nasdaq IPO". The Economic Times. Retrieved 28 April 2024.
^ "Indegene on the prowl for global acquisitions". The Hindu Businessline. 12 August 2020. Retrieved 8 January 2023.
^ ^a ^b ^c "PE firms Carlyle, Nadathur Fareast, Brighton Park Capital-backed Indegene IPO to open on May 6". Moneycontrol. Retrieved 28 April 2024.
^ ^a ^b Murayama, Keiichi (19 February 2015). "India's tech muscle has the world's attention". The Nikkei. Retrieved 2 October 2015.
^ Das, Avik (2 September 2015). "Flipkart, Practo CEOs get top rating from staff". The Economic Times. Retrieved 2 October 2015.
^ Singh, Seema (7 May 2009). "Cutting pharma costs by intelligent marketing". Mint. Retrieved 2 October 2015.
^ Unnikrishnan, CH (8 November 2006). "Indegene buys US firm". Business Standard. Retrieved 2 October 2015.
^ "Indegene files papers with Sebi; eyes ₹3,200 crore via IPO". mint. 15 December 2022. Retrieved 8 January 2023.

[1] Mendonca, Jochelle (28 November 2015). "Healthcare IT firm Indegene targets $250 million in revenue by 2020, looking at Nasdaq IPO". The Economic Times. Retrieved 28 April 2024.

[2] "Indegene on the prowl for global acquisitions". The Hindu Businessline. 12 August 2020. Retrieved 8 January 2023.

[fy23-3] "PE firms Carlyle, Nadathur Fareast, Brighton Park Capital-backed Indegene IPO to open on May 6". Moneycontrol. Retrieved 28 April 2024.

[Nikkei-4] Murayama, Keiichi (19 February 2015). "India's tech muscle has the world's attention". The Nikkei. Retrieved 2 October 2015.

[ETKart-5] Das, Avik (2 September 2015). "Flipkart, Practo CEOs get top rating from staff". The Economic Times. Retrieved 2 October 2015.

[Mint-6] Singh, Seema (7 May 2009). "Cutting pharma costs by intelligent marketing". Mint. Retrieved 2 October 2015.

[BS2006-7] Unnikrishnan, CH (8 November 2006). "Indegene buys US firm". Business Standard. Retrieved 2 October 2015.

[Revenue-8] "Indegene files papers with Sebi; eyes ₹3,200 crore via IPO". mint. 15 December 2022. Retrieved 8 January 2023.

Indegene information

and 28 Related for: Indegene information

Indegene

Accenture

Optum

Wipro

HCLTech

Tech Mahindra

UnitedHealth Group

Clarivate

Syneos Health

PRA Health Sciences

Veeva Systems

LTIMindtree

Informa

Medidata Solutions

Labcorp Drug Development

List of festivals in Nigeria

Olubola Babalola

George Institute for Global Health

Awomukwu

Wolfe Laboratories

Craven Laboratories

Coloured people in Namibia

Cytel

Cancer Trials Support Unit

Simon Edem Asimah

Yakubu Musa Katsina

WIL Research Laboratories

Creole music


Formerly	Indegene Lifesystems^[1]
Company type	Public
Traded as	NSE: INDGN BSE: 544172
Industry	Contract research Health information technology
Founded	1998; 26 years ago (1998)
Founders	Rajesh Nair Manish Gupta Sanjay Parikh Anand Kiran Gaurav Kapoor
Headquarters	Bangalore , India
Area served	Worldwide
Key people	Manish Gupta (CEO)^[2]
Revenue	₹2,306 crore (US$290 million) (FY23)^[3]
Net income	₹266 crore (US$33 million) (FY23)^[3]
Owners	N. S. Raghavan (23.64%) Carlyle Group (20.42%) Brighton Park Capital (12.07%)^[3]
Number of employees	4,100 (2021)^[4]
Website	www.indegene.com